Bemnifosbuvir hemisulfate

Overview

Bemnifosbuvir hemisulfate (AT-527), a hemisulfate salt of AT-511, a guanosine nucleotide proagent, is a potent and orally active HCV viral replication inhibitor. Bemnifosbuvir hemisulfate is highly effective in the control of SARS-CoV-2 (COVID-19) infection in vitro ( EC 90 =0.47 μM). Bemnifosbuvir hemisulfate has pangenotypic antiviral activity.

Application

Products | Products > Disease Areas > Infection | Products > Disease Areas > Hepatitis Virus Infection | Products > Disease Areas > Viral Infection | Products > Disease Areas > Hepatitis C Virus Infection | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Signaling Pathways > HCV | Products > Signaling Pathways > SARS-CoV

Product Information

• Catalog No.: HY-137958
• CAS No.: 2241337-84-6
• Molecular Formula: C24H33FN7O7P.1/2H2O4S
• Molecular Weight: 630.58
• Purity: 99.22%
• Storage: 4°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Solubility: ≥ 5 mg/mL (7.93 mM); Clear solution
• Availability: In-stock

Source

Original product source